Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Down 6.9% in January

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) saw a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 5,510,000 shares, a drop of 6.9% from the January 15th total of 5,920,000 shares. Based on an average daily volume of 1,570,000 shares, the days-to-cover ratio is currently 3.5 days.

Institutional Trading of Acadia Healthcare

A number of large investors have recently modified their holdings of the stock. Caisse DE Depot ET Placement DU Quebec purchased a new position in Acadia Healthcare in the fourth quarter worth approximately $4,480,000. Freestone Grove Partners LP purchased a new stake in Acadia Healthcare during the 4th quarter worth about $29,943,000. 8 Knots Management LLC boosted its position in shares of Acadia Healthcare by 28.9% during the 4th quarter. 8 Knots Management LLC now owns 656,963 shares of the company’s stock worth $26,049,000 after acquiring an additional 147,351 shares in the last quarter. Northern Trust Corp raised its position in shares of Acadia Healthcare by 29.8% during the 4th quarter. Northern Trust Corp now owns 863,066 shares of the company’s stock worth $34,221,000 after acquiring an additional 198,243 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in Acadia Healthcare by 33.5% in the fourth quarter. The Manufacturers Life Insurance Company now owns 487,596 shares of the company’s stock valued at $19,333,000 after purchasing an additional 122,358 shares in the last quarter.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Barclays dropped their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. TD Cowen dropped their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $70.22.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $41.06 on Monday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $42.09 and a 200 day moving average price of $53.90. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The stock has a market cap of $3.81 billion, a P/E ratio of 13.46, a PEG ratio of 1.75 and a beta of 1.30.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.